Carlsmed, Inc.
CARL
$9.99
-$0.87-8.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 15.99% | 8.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.99% | 8.20% | |||
| Cost of Revenue | 13.03% | -2.08% | |||
| Gross Profit | 16.93% | 11.93% | |||
| SG&A Expenses | 7.89% | 29.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.74% | 18.96% | |||
| Operating Income | -3.13% | -38.96% | |||
| Income Before Tax | -1.02% | -26.01% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.02% | -26.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.02% | -26.01% | |||
| EBIT | -3.13% | -38.96% | |||
| EBITDA | -2.98% | -39.00% | |||
| EPS Basic | 19.93% | 72.57% | |||
| Normalized Basic EPS | 19.94% | 72.56% | |||
| EPS Diluted | 19.93% | 72.57% | |||
| Normalized Diluted EPS | 19.94% | 72.56% | |||
| Average Basic Shares Outstanding | 26.16% | 359.32% | |||
| Average Diluted Shares Outstanding | 26.16% | 359.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||